drugset
drugset / Trial / NCT00791817

Study to Evaluate Potential Food Effects

NCT00791817 ↗

Phase 1 Completed 10 enrolled Procter and Gamble
RandomizedCrossoverOpen-label

Summary

Half the group will be given a high fat diet and the other half will fast. They will then be crossed over.

Timeline

Start
2005-08
Primary completion
2006-01
Completion
2006-01

Drugs

EvaluationDrugModalityDoseRoute
Subject PG-760564 Unknown 200 mg Oral

Indications

No indication recorded.